Abiopharma

🔍 Mackey James G. (Executive)

Company: BankUnited, Inc. (BKU)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Acquired 8,937 shares of Common Stock, par value $0.01 (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 8,937.00 | transaction_form_type: 4
• Sold 3,517 shares of Common Stock, par value $0.01 at $46.83 per share (Direct)
  Date: 2026-08-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 5,420.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 8,937 shares of Restricted Share Unit (Derivative)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 26,731.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3

Footnotes:

• F1: Shares of BankUnited, Inc. common stock withheld by the Issuer to satisfy the tax withholding obligation of the reporting person arising from the vesting of restricted shares on August 20, 2026. These shares were not sold by the reporting person but were instead withheld from the total number of vested shares received by the reporting person from the Issuer.
• F2: Each restricted share unit represents the right to receive, at settlement, one share of common stock or cash in an amount equal to the fair market value of one share of common stock.
• F3: Issued pursuant to the terms of the BankUnited, Inc. 2023 Omnibus Equity Incentive Plan. 8,937 units vested on August 20, 2026, 8,936 units will vest on August 20, 2027, and 8,937 will vest on August 20, 2028.